The concomitant use of VYVANSE and CYP2D6 inhibitors may increase the exposure of dextroamphetamine, the active metabolite of VYVANSE compared to the use of the drug alone and increase the risk of serotonin syndrome. The delayed onset is good for kids who may have a longer commute to school, Dr. https://clarencen480jpv1.wikijm.com/user